Barclays’s Processa Pharmaceuticals PCSA Stock Holding History

Barclays’s Portfolio PCSA Stock Details PCSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5	Buy	+3	New	+$6	﹤0.01%	5245

Other funds holding PCSA

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Barclays's PCSA Position: Q3 2026 in Review

Barclays opened a new position in Processa Pharmaceuticals (PCSA) in Q3 2026: 3 shares worth $5. The stake represents ﹤0.01% of the portfolio and ranks #5245 among its holdings.

2 funds tracked by Wall St. Rank hold PCSA as of Q3 2026.

Barclays held 3 shares of Processa Pharmaceuticals worth $5 as of Q3 2026.
Processa Pharmaceuticals was a new Barclays position in Q3 2026.
Processa Pharmaceuticals made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5245 holding.
2 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.